This application discloses a compound, its preparation method, pharmaceutical composition, and application, belonging to the field of pharmaceutical synthesis and application technology. The compound is selected from formula (I) or formula (II). This compound can improve oral
bioavailability, enabling
oral administration and solving a series of problems associated with injecting
fulvestrant in clinical practice.
In vivo, it can be metabolized to produce
fulvestrant and can inhibit / degrade
estrogen receptor prodrug molecules, treating
estrogen receptor-related diseases.